-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
A few days ago, the National Bureau of Statistics released industrial economic operation data.
From January to February 2022, the operating income of China's pharmaceutical manufacturing enterprises above designated size (the same below) was 429.
51 billion yuan, a year-on-year increase of 2.
3% according to the caliber of comparable income; the total profit of the pharmaceutical manufacturing industry was 683 million yuan.
100 million yuan, down 17.
6% year-on-year
.
From January to February 2022, the operating income of China's pharmaceutical manufacturing enterprises above designated size (the same below) was 429.
51 billion yuan, a year-on-year increase of 2.
3% according to the caliber of comparable income; the total profit of the pharmaceutical manufacturing industry was 683 million yuan.
100 million yuan, down 17.
6% year-on-year
.
Operating income of pharmaceutical manufacturing enterprises above designated size in the past year
The total profit of pharmaceutical manufacturing enterprises above designated size in the past year
The profit margin trend of the pharmaceutical manufacturing industryin the past year
Affected by the high base last year, the growth rate of revenue and profit of the pharmaceutical manufacturing industry both decreased significantly compared with the same period last year
.
.
It is worth noting that the rapid growth of pharmaceutical manufacturing revenue (up 37.
7% year-on-year) and profit (up 95.
4% year-on-year) in January-February 2021 is a rebound from the low base in 2020, and by 2022, Basically back to the steady growth situation before the epidemic
.
7% year-on-year) and profit (up 95.
4% year-on-year) in January-February 2021 is a rebound from the low base in 2020, and by 2022, Basically back to the steady growth situation before the epidemic
.
However, before the year-on-year epidemic, the growth rate of the pharmaceutical manufacturing industry's revenue also slowed down significantly from January to February this year, especially the negative growth in profits, and production and operation are facing challenges
.
.
From the same period in the past four years,
From January to February 2019, both the revenue and profit of the pharmaceutical manufacturing industry maintained single-digit growth;
From January to February 2020, due to the impact of the new crown epidemic, the revenue and profit of the pharmaceutical manufacturing industry declined at the same time;
From January to February 2021, due to the small base of the previous year, the revenue and profits of the pharmaceutical manufacturing industry showed a rapid growth trend, especially the total profit, which increased by as much as 95.
4% year-on-year
.
4% year-on-year
.
A few days ago, the National Bureau of Statistics released industrial economic operation data.
From January to February 2022, the operating income of China's pharmaceutical manufacturing enterprises above designated size (the same below) was 429.
51 billion yuan, a year-on-year increase of 2.
3% according to the caliber of comparable income; the total profit of the pharmaceutical manufacturing industry was 683 million yuan.
100 million yuan, down 17.
6% year-on-year
.
From January to February 2022, the operating income of China's pharmaceutical manufacturing enterprises above designated size (the same below) was 429.
51 billion yuan, a year-on-year increase of 2.
3% according to the caliber of comparable income; the total profit of the pharmaceutical manufacturing industry was 683 million yuan.
100 million yuan, down 17.
6% year-on-year
.
Operating income of pharmaceutical manufacturing enterprises above designated size in the past year
The total profit of pharmaceutical manufacturing enterprises above designated size in the past year
The profit margin trend of the pharmaceutical manufacturing industry in the past year
Affected by the high base last year, the growth rate of revenue and profit of the pharmaceutical manufacturing industry both decreased significantly compared with the same period last year
.
.
It is worth noting that the rapid growth of pharmaceutical manufacturing revenue (up 37.
7% year-on-year) and profit (up 95.
4% year-on-year) in January-February 2021 is a rebound from the low base in 2020, and by 2022, Basically back to the steady growth situation before the epidemic
.
7% year-on-year) and profit (up 95.
4% year-on-year) in January-February 2021 is a rebound from the low base in 2020, and by 2022, Basically back to the steady growth situation before the epidemic
.
However, before the year-on-year epidemic, the growth rate of the pharmaceutical manufacturing industry's revenue also slowed down significantly from January to February this year, especially the negative growth in profits, and production and operation are facing challenges
.
.
From the same period in the past four years,
From January to February 2019, both the revenue and profit of the pharmaceutical manufacturing industry maintained single-digit growth;
From January to February 2020, due to the impact of the new crown epidemic, the revenue and profit of the pharmaceutical manufacturing industry declined at the same time;
From January to February 2021, due to the small base of the previous year, the revenue and profits of the pharmaceutical manufacturing industry showed a rapid growth trend, especially the total profit, which increased by as much as 95.
4% year-on-year
.
4% year-on-year
.
A few days ago, the National Bureau of Statistics released industrial economic operation data.
From January to February 2022, the operating income of China's pharmaceutical manufacturing enterprises above designated size (the same below) was 429.
51 billion yuan, a year-on-year increase of 2.
3% according to the caliber of comparable income; the total profit of the pharmaceutical manufacturing industry was 683 million yuan.
100 million yuan, down 17.
6% year-on-year
.
From January to February 2022, the operating income of China's pharmaceutical manufacturing enterprises above designated size (the same below) was 429.
51 billion yuan, a year-on-year increase of 2.
3% according to the caliber of comparable income; the total profit of the pharmaceutical manufacturing industry was 683 million yuan.
100 million yuan, down 17.
6% year-on-year
.
Operating income of pharmaceutical manufacturing enterprises above designated size in the past year
The total profit of pharmaceutical manufacturing enterprises above designated size in the past year
The profit margin trend of the pharmaceutical manufacturing industry in the past year
Medicine and medicine Affected by the high base last year, the growth rate of revenue and profit of the pharmaceutical manufacturing industry both decreased significantly compared with the same period last year
.
.
It is worth noting that the rapid growth of pharmaceutical manufacturing revenue (up 37.
7% year-on-year) and profit (up 95.
4% year-on-year) in January-February 2021 is a rebound from the low base in 2020, and by 2022, Basically back to the steady growth situation before the epidemic
.
7% year-on-year) and profit (up 95.
4% year-on-year) in January-February 2021 is a rebound from the low base in 2020, and by 2022, Basically back to the steady growth situation before the epidemic
.
However, before the year-on-year epidemic, the growth rate of the pharmaceutical manufacturing industry's revenue also slowed down significantly from January to February this year, especially the negative growth in profits, and production and operation are facing challenges
.
.
From the same period in the past four years,
From the same period in the past four years, From January to February 2019, both the revenue and profit of the pharmaceutical manufacturing industry maintained single-digit growth;
From January to February 2020, due to the impact of the new crown epidemic, the revenue and profit of the pharmaceutical manufacturing industry declined at the same time;
From January to February 2021, due to the small base of the previous year, the revenue and profits of the pharmaceutical manufacturing industry showed a rapid growth trend, especially the total profit, which increased by as much as 95.
4% year-on-year
.
4% year-on-year
.
